MarkChristopherBenyunesMD

PubMed

• 10 citations
  Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study
  Sherko Kuemmel, Carlo Tondini, Jacinta Abraham, Zbigniew Nowecki, Bartosz Itrych, Erika Hitre, Boguslawa Karaszewska, Alejandro Juárez-Ramiro, Flavia Morales-Vásquez, ...> ;Breast Cancer Research and Treatment. 2021 Mar 21
• 378 citations
  Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled...
  Sandra M Swain, David Miles, Sung Bae Kim, Young-Hyuck Im, Seock-Ah Im, Vladimir Semiglazov, Eva Ciruelos, Andreas Schneeweiss, Sherene Loi, Estefania Monturus, Emma C...> ;The Lancet. Oncology. 2020 Apr 1
• 827 citations
  Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
  Gunter von Minckwitz, Marion Procter, Evandro de Azambuja, Dimitrios Zardavas, Mark C. Benyunes, Giuseppe Viale, Thomas M. Suter, Amal Arahmani, Nathalie Rouchet, Emma...> ;The New England Journal of Medicine. 2017 Jun 5
• 17 citations
  Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer
  Angelica Quartino, Hanbin Li, Jin Y. Jin, D. Russell Wada, Mark C. Benyunes, V. McNally, Lucia Viganò, Ihsan Nijem, Bert L. Lum, Amit Garg> ;Cancer Chemotherapy and Pharmacology. 2017 Jan 10
• 1304 citations
  Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
  Sandra M. Swain, José Baselga, Sung-Bae Kim, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Sarah Heeson, Emma C...> ;The New England Journal of Medicine. 2015 Feb 18
• 690 citations
  Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-...
  Sandra M. Swain, Sung-Bae Kim, Javier Cortes, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Adam Knott, Emma Cl...> ;The Lancet. Oncology. 2013 May 1
• 124 citations
  Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Pl...
  Sandra M. Swain, Michael S. Ewer, Javier Cortes, Dino Amadori, David Miles, Adam Knott, Emma Clark, Mark C. Benyunes, Graham Ross, José Baselga> ;The Oncologist. 2013 Mar 1
• 1741 citations
  Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
  José Baselga, Javier Cortes, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Young-Hyuck Im, L Roman, Jose Luiz Pedrini, Tadeusz Pienkowski, Adam Knott, Emma Clark, Mark C. B...> ;The New England Journal of Medicine. 2012 Jan 11
• 111 citations
  Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma
  Myron S. Czuczman, A. Koryzna, A. Mohr, C. Stewart, K. Donohue, L. Blumenson, Z. P. Bernstein, P. McCarthy, A. Alam, F. Hernandez-Ilizaliturri, M. Skipper, K. Brown, A...> ;Journal of Clinical Oncology. 2005 Feb 1
• 15 citations
  No clinical evidence for CD4+ cell depletion caused by rituximab
  M. Wayne Saville, Mark C. Benyunes, Pratik S. Multani> ;Blood. 2003 Jul 1
• 23 citations
  Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
  Charles A. Linker, Paolo Anderlini, Roger H. Herzig, N. P. Christiansen, George Somlo, William I. Bensinger, Joseph W. Fay, Joseph P. Lynch, Lawrence T. Goodnough, Mar...> ;Biology of Blood and Marrow Transplantation. 2003 Jun 1
• 12 citations
  Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
  James Gajewski, Gabriela Rondon, Michele L. Donato, Paolo Anderlini, Martin Korbling, Cindy Ippoliti, Mark Benyunes, Langdon L Miller, Denise LaTemple, Denny Jones, Ma...> ;Biology of Blood and Marrow Transplantation. 2002 Oct 1
• Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
  Fallon, A., Mohr, A., Grillo-López, A. J., Stewart, C., Wentling, D., Klippenstein, D., Brown, K., Miller, K., Skipper, M., Benyunes, M., Rock, M. K., Czuczman, M. S.,...> ;Semin Oncol. 2002 Feb
• Rituximab: ongoing and future clinical development.
  Grillo-López, A. J., Hedrick, E., Benyunes, M., Rashford, M.> ;Semin Oncol. 2002 Feb
• Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple ...
  Stewart, A. K., Vescio, R., Schiller, G., Ballester, O., Noga, S., Rugo, H., Freytes, C., Stadtmauer, E., Tarantolo, S., Sahebi, F., Stiff, P., Meharchard, J., Schloss...> ;J Clin Oncol. 2001 Sep 1
• 20 citations
  Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study
  S. N. Wolff, Roger H. Herzig, Lynch J, Ericson Sg, John P. Greer, Richard S. Stein, Stacey Goodman, Mark C. Benyunes, Mark Ashby, Dennie V. Jones, Joseph W. Fay> ;Bone Marrow Transplantation. 2001 Feb 1
• 113 citations
  Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update.
  Lori Kunkel, Alvin Wong, Tom Maneatis, James Nickas, T. D. Brown, Antonio J. Grillo-Lopez, Mark Benyunes, Barry Grobman, Robert O. Dillman> ;Seminars in Oncology. 2000 Dec 1
• Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
  Stewart, A. K., Freytes, C., Jacobs, C., Stadtmauer, E., Sahebi, F., Schiller, G., Rugo, H., Tully, H., Berenson, J., DiPersio, J., Meharchard, J., Anderson, K., Benyu...> ;Blood. 1999 Mar 15
• Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.
  Fefer, A., Lindgren, C., Thompson, J. A., Benyunes, M. C., Robinson, N., Press, O., Bensinger, W. I.> ;Cancer J Sci Am. 1997 Dec
• 35 citations
  Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
  Nanette Robinson, M. Benyunes, John A. Thompson, A York, Stephen H. Petersdorf, Oliver W. Press, Catherine G. Lindgren, Thomas R. Chauncey, Buckner Cd, William I. Bens...> ;Bone Marrow Transplantation. 1997 Mar 1
• Steroid-refractory cutaneous graft-versus-host disease after transplantation of haploidentical parental CD34+ cells in children with Down's syndrome and recurrent acut...
  Yeager, A. M., Turner, C. W., Holland, H. K., Forte, K. J., Benyunes, M. C., Mogul, M. J.> ;J Pediatr Hematol Oncol. 1997 Mar 01
• 131 citations
  Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
  William I. Bensinger, Buckner Cd, Kathleen Shannon-Dorcy, Scott D. Rowley, FR Appelbaum, M. Benyunes, Reginald A. Clift, P.J. Martin, Taner Demirer, Rainer Storb, M Le...> ;Blood. 1996 Dec 1
• Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
  Massumoto, C., Benyunes, M. C., Sale, G., Beauchamp, M., York, A., Thompson, J. A., Buckner, C. D., Fefer, A.> ;Bone Marrow Transplant. 1996 Mar
• 37 citations
  Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia
  Nanette Robinson, Jean E. Sanders, M. Benyunes, Kathy Beach, Catherine G. Lindgren, John A. Thompson, Frederick R. Appelbaum, A Fefer> ;Blood. 1996 Feb 15
• Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility t...
  Fefer, A., York, A., Higuchi, C., Lindgren, C., Buckner, C. D., Thompson, J. A., Benyunes, M. C.> ;Bone Marrow Transplant. 1995 Aug
• Join now to see all